Showing results (471-480 of 482) with videos related to
Sort By:
Pageof 49
The Lancet. Infectious Diseases|March 19, 2013
Sofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naive patients with genotypes 1, 2, and 3 hepatitis C infection: a randomised, double-blind, phase 2 trialEric Lawitz, Jay P Lalezari, Tarek Hassanein, et al.Gastroenterology|November 9, 2024
Phase 3 Validation of PAaM for Hepatocellular Carcinoma Risk Stratification in CirrhosisNaoto Fujiwara, Camden Lopez, Tracey L Marsh, et al.Gastroenterology|May 20, 2015
Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver DiseaseMichael Charlton, Gregory T Everson, Steven L Flamm, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 23, 2018
GALAD Score for Hepatocellular Carcinoma Detection in Comparison with Liver Ultrasound and Proposal of GALADUS ScoreJu Dong Yang, Benyam D Addissie, Kristin C Mara, et al.Annals of Internal Medicine|April 5, 2016
Outcomes in Adults With Acute Liver Failure Between 1998 and 2013: An Observational Cohort StudyAdrian Reuben, Holly Tillman, Robert J Fontana, et al.The New England Journal of Medicine|June 1, 2017
Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV InfectionMarc Bourlière, Stuart C Gordon, Steven L Flamm, et al.Hepatology International|November 15, 2024
Non-cirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and managementAkash Shukla, Don C Rockey, Patrick S Kamath, et al.Gastroenterology|July 25, 2025
Enhancement of Inpatient Mortality Prognostication With Machine Learning in a Prospective Global Cohort of Patients With Cirrhosis With External ValidationScott Silvey, Patrick S Kamath, Jacob George, et al.Gut|June 5, 2026
Chronic kidney disease in cirrhosis: a study of inpatients from a global perspectiveFlorence Wong, Danielle Adebayo, Jacob George, et al.The American Journal of Gastroenterology|April 27, 2026
Machine Learning Models Using Hospital Admission Characteristics Do Not Optimally Predict Nosocomial Infection Development in a Global Cirrhosis CohortScott Silvey, Ashok K Choudhury, Patrick S Kamath, et al.Pageof 49